CN Patent
CN101352421A — 一种制备基本上非结晶形式的替米沙坦的方法
Assigned to Boehringer Ingelheim Pharma GmbH and Co KG · Expires 2009-01-28 · 17y expired
What this patent protects
本发明涉及一种制备基本上非结晶形式的替米沙坦的方法,包括a)制备包含替米沙坦以及至少一种碱性试剂的水溶液;b)喷雾干燥所述的含水溶液以得到喷雾干燥的颗粒。
USPTO Abstract
本发明涉及一种制备基本上非结晶形式的替米沙坦的方法,包括a)制备包含替米沙坦以及至少一种碱性试剂的水溶液;b)喷雾干燥所述的含水溶液以得到喷雾干燥的颗粒。
Drugs covered by this patent
- Sustiva (EFAVIRENZ) · Bristol-Myers Squibb
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.